Literature DB >> 26809495

Older Is Not Wiser, Immunologically Speaking: Effect of Aging on Host Response to Clostridium difficile Infections.

Jae Hyun Shin1, Kevin P High2, Cirle A Warren3.   

Abstract

Clostridium difficile infection (CDI) is the most common cause of antibiotic-associated diarrhea and a significant burden on the health care system. Aging has been identified in the literature as a risk factor for CDI as well as adverse outcome from CDI. Although this effect of advanced age on CDI could be partially explained by clinical factors associated with aging, biologic factors are important. Innate immune system, responsible for immediate response to acute infections, plays a major role in CDI pathogenesis. Impairment in function of innate immunity with aging, demonstrated in other infection models, may lead to worse outcome with CDI. C. difficile toxin-specific antibody response protects the host against initial and recurrent infections as shown in observational studies and clinical trial. Effect of aging on antibody response to CDI has not been demonstrated, but the results from vaccine studies in other infections suggest a negative effect on humoral immunity from aging. Although intestinal microbiota from healthy people confers resistance to CDI by preventing C. difficile colonization, changes in composition of microbiota with aging may affect that resistance and increase risk for CDI. There are also age-associated changes in physiology, especially of the gastrointestinal tract, that may play a role in CDI risk and outcomes. In this review, we will first discuss the epidemiology of CDI in the elderly people, then the alteration in innate immunity, humoral response, and microbiota that increases susceptibility to CDI and severe disease and lastly, the physiological and functional changes that may modify outcomes of infection.
© The Author 2016. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Epidemiology; Functional Performance.; Immune Function; Infection; Inflammation

Mesh:

Year:  2016        PMID: 26809495      PMCID: PMC4906326          DOI: 10.1093/gerona/glv229

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  52 in total

Review 1.  Ineffective humoral immunity in the elderly.

Authors:  Kiley S McGlauchlen; Laura A Vogel
Journal:  Microbes Infect       Date:  2003-11       Impact factor: 2.700

2.  Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec.

Authors:  Jacques Pépin; Louis Valiquette; Benoit Cossette
Journal:  CMAJ       Date:  2005-09-22       Impact factor: 8.262

3.  Age-related differences in the neutrophil response to pulmonary pseudomonas infection.

Authors:  Michael M Chen; Jessica L Palmer; Timothy P Plackett; Cory R Deburghgraeve; Elizabeth J Kovacs
Journal:  Exp Gerontol       Date:  2014-01-05       Impact factor: 4.032

4.  Nucleotide-binding oligomerization domain 1 mediates recognition of Clostridium difficile and induces neutrophil recruitment and protection against the pathogen.

Authors:  Mizuho Hasegawa; Takashi Yamazaki; Nobuhiko Kamada; Kazuki Tawaratsumida; Yun-Gi Kim; Gabriel Núñez; Naohiro Inohara
Journal:  J Immunol       Date:  2011-03-16       Impact factor: 5.422

5.  Co-morbidity, not age predicts adverse outcome in clostridium difficile colitis.

Authors:  TS Dharmarajan; M Sipalay; R Shyamsundar; EP Norkus; CS Pitchumoni
Journal:  World J Gastroenterol       Date:  2000-04       Impact factor: 5.742

6.  Treatment with monoclonal antibodies against Clostridium difficile toxins.

Authors:  Israel Lowy; Deborah C Molrine; Brett A Leav; Barbra M Blair; Roger Baxter; Dale N Gerding; Geoffrey Nichol; William D Thomas; Mark Leney; Susan Sloan; Catherine A Hay; Donna M Ambrosino
Journal:  N Engl J Med       Date:  2010-01-21       Impact factor: 91.245

7.  Interaction between Clostridium difficile and polymorphonuclear leucocytes from the elderly and post-operative cancer patients: phagocytosis and bactericidal function.

Authors:  H P Bassaris; P E Lianou; N J Legakis; J T Papavassiliou
Journal:  Med Microbiol Immunol       Date:  1984       Impact factor: 3.402

Review 8.  Active and passive immunization against Clostridium difficile diarrhea and colitis.

Authors:  Paul J Giannasca; Michel Warny
Journal:  Vaccine       Date:  2004-02-17       Impact factor: 3.641

9.  Neutrophil recruitment in Clostridium difficile toxin A enteritis in the rabbit.

Authors:  C P Kelly; S Becker; J K Linevsky; M A Joshi; J C O'Keane; B F Dickey; J T LaMont; C Pothoulakis
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

10.  Multistate point-prevalence survey of health care-associated infections.

Authors:  Shelley S Magill; Jonathan R Edwards; Wendy Bamberg; Zintars G Beldavs; Ghinwa Dumyati; Marion A Kainer; Ruth Lynfield; Meghan Maloney; Laura McAllister-Hollod; Joelle Nadle; Susan M Ray; Deborah L Thompson; Lucy E Wilson; Scott K Fridkin
Journal:  N Engl J Med       Date:  2014-03-27       Impact factor: 91.245

View more
  12 in total

1.  A cross-sectional comparison of ethanol-related cytokine expression in the hippocampus of young and aged Fischer 344 rats.

Authors:  Anny Gano; Tamara L Doremus-Fitzwater; Terrence Deak
Journal:  Neurobiol Aging       Date:  2017-03-17       Impact factor: 4.673

2.  Phase 1 Study To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Oral Doses of DS-2969b, a Novel GyrB Inhibitor, in Healthy Subjects.

Authors:  Alexander G Vandell; Satoshi Inoue; Justin Dennie; Yasuo Nagasawa; Roohi Gajee; Joe Pav; George Zhang; Cynthia Zamora; Nobuhisa Masuda; Giorgio Senaldi
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

Review 3.  Control of Clostridium difficile Infection by Defined Microbial Communities.

Authors:  James Collins; Jennifer M Auchtung
Journal:  Microbiol Spectr       Date:  2017-09

4.  Innate Immune Response and Outcome of Clostridium difficile Infection Are Dependent on Fecal Bacterial Composition in the Aged Host.

Authors:  Jae Hyun Shin; Yingnan Gao; John H Moore; David T Bolick; Glynis L Kolling; Martin Wu; Cirle A Warren
Journal:  J Infect Dis       Date:  2018-01-04       Impact factor: 5.226

Review 5.  Collateral damage during antibiotic treatment of C. difficile infection in the aged host: Insights into why recurrent disease happens.

Authors:  Jae Hyun Shin; Cirle A Warren
Journal:  Gut Microbes       Date:  2017-04-28

6.  Clostridium difficile bacteremia: Report of two cases in French hospitals and comprehensive review of the literature.

Authors:  Mouna Doufair; Catherine Eckert; Laurence Drieux; Come Amani-Moibeni; Liliane Bodin; Michel Denis; Jean Didier Grange; Guillaume Arlet; Frédéric Barbut
Journal:  IDCases       Date:  2017-03-28

7.  Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients aged ≥60 years (EXTEND): analysis of cost-effectiveness.

Authors:  Oliver A Cornely; Maureen Watt; Charles McCrea; Simon D Goldenberg; Enrico De Nigris
Journal:  J Antimicrob Chemother       Date:  2018-09-01       Impact factor: 5.790

8.  The pleiotropic effects of prebiotic galacto-oligosaccharides on the aging gut.

Authors:  Jason W Arnold; Jeffery Roach; Salvador Fabela; Emily Moorfield; Shengli Ding; Eric Blue; Suzanne Dagher; Scott Magness; Rita Tamayo; Jose M Bruno-Barcena; M Andrea Azcarate-Peril
Journal:  Microbiome       Date:  2021-01-28       Impact factor: 16.837

Review 9.  Challenges for Clinical Development of Vaccines for Prevention of Hospital-Acquired Bacterial Infections.

Authors:  Isabelle Bekeredjian-Ding
Journal:  Front Immunol       Date:  2020-08-05       Impact factor: 7.561

10.  Fecal Microbial Enterotypes Differentially Respond to a High-fat Diet Based on Sex in Fischer-344 Rats.

Authors:  Soo In Choi; Nayoung Kim; Ryoung Hee Nam; Ji Hyun Park; Heewon Nho; Jeong Eun Yu; Chin-Hee Song; Sun Min Lee; Dong Ho Lee
Journal:  J Cancer Prev       Date:  2021-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.